J

Jafron Biomedical Co Ltd
SZSE:300529

Watchlist Manager
Jafron Biomedical Co Ltd
SZSE:300529
Watchlist
Price: 31.81 CNY 1.4% Market Closed
Market Cap: 25.7B CNY
Have any thoughts about
Jafron Biomedical Co Ltd?
Write Note

Jafron Biomedical Co Ltd
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jafron Biomedical Co Ltd
Operating Income Peer Comparison

Comparables:
A
688617
J
002223
300760
L
300003
688271

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
J
Jafron Biomedical Co Ltd
SZSE:300529
Operating Income
ÂĄ856.6m
CAGR 3-Years
-11%
CAGR 5-Years
9%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Operating Income
ÂĄ574.3m
CAGR 3-Years
69%
CAGR 5-Years
87%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Operating Income
ÂĄ1.8B
CAGR 3-Years
-2%
CAGR 5-Years
17%
CAGR 10-Years
20%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Operating Income
ÂĄ13.5B
CAGR 3-Years
17%
CAGR 5-Years
24%
CAGR 10-Years
N/A
L
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
Operating Income
ÂĄ1.3B
CAGR 3-Years
-23%
CAGR 5-Years
-7%
CAGR 10-Years
11%
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Operating Income
ÂĄ1.9B
CAGR 3-Years
17%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Jafron Biomedical Co Ltd's Operating Income?
Operating Income
856.6m CNY

Based on the financial report for Jun 30, 2024, Jafron Biomedical Co Ltd's Operating Income amounts to 856.6m CNY.

What is Jafron Biomedical Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
9%

Over the last year, the Operating Income growth was 84%. The average annual Operating Income growth rates for Jafron Biomedical Co Ltd have been -11% over the past three years , 9% over the past five years .

Back to Top